CAMPHOR

CAMPHOR was reported 1246 times

CAMPHOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA THERMAL 20 0.1408
1 PANCREASTATIN INCREASED 1 0.1250
2 ADMINISTRATION SITE ERYTHEMA 14 0.0491
3 NOTALGIA PARAESTHETICA 1 0.0476
4 NON-NEUTRALISING ANTIBODIES POSITIVE 1 0.0244
5 PACEMAKER COMPLICATION 1 0.0164
6 ABDOMINAL WALL OEDEMA 1 0.0159
7 AUTOPHONY 1 0.0133
8 VOCAL CORD CYST 1 0.0102
9 ANAL POLYP 1 0.0097
10 ANAL EROSION 1 0.0091
11 AMYLASE DECREASED 1 0.0090
12 SCLERAL HAEMORRHAGE 2 0.0087
13 INCISION SITE INFLAMMATION 1 0.0085
14 ABDOMINAL WALL CYST 1 0.0082
15 CARBUNCLE 2 0.0071
16 SERRATIA BACTERAEMIA 1 0.0068
17 BLOOD CHLORIDE ABNORMAL 1 0.0062
18 LACTOBACILLUS INFECTION 1 0.0061
19 OESOPHAGEAL HYPOMOTILITY 1 0.0057
20 BASOPHIL PERCENTAGE INCREASED 1 0.0057
21 NEUROTRANSMITTER LEVEL ALTERED 1 0.0053
22 SMOOTH MUSCLE ANTIBODY POSITIVE 1 0.0053
23 DEAFNESS PERMANENT 1 0.0051
24 VITAMIN B12 DEFICIENCY 20 0.0049
25 SALMONELLA BACTERAEMIA 1 0.0048
26 ANTICHOLINERGIC SYNDROME 7 0.0044
27 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 1 0.0040
28 AUTOANTIBODY POSITIVE 1 0.0036
29 BURNS FIRST DEGREE 1 0.0035
30 VOCAL CORD INFLAMMATION 1 0.0034
31 INCISION SITE SWELLING 1 0.0033
32 PIGMENTATION DISORDER 20 0.0032
33 PSEUDOCIRRHOSIS 1 0.0030
34 SMALL INTESTINAL PERFORATION 5 0.0027
35 ALBUMIN URINE PRESENT 1 0.0026
36 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
37 GRANULOCYTE COUNT INCREASED 1 0.0025
38 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
39 SKIN PLAQUE 20 0.0024
40 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
41 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
42 LARGE INTESTINAL OBSTRUCTION 5 0.0022
43 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
44 DIZZINESS POSTURAL 21 0.0022
45 PILONIDAL CYST 1 0.0020
46 INFUSION SITE ABSCESS 1 0.0020
47 SCRATCH 20 0.0019
48 ENCEPHALOMALACIA 1 0.0018
49 SECRETION DISCHARGE 20 0.0016
50 CLEFT PALATE 3 0.0016
51 SICKLE CELL ANAEMIA 1 0.0016
52 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
53 LICHEN SCLEROSUS 1 0.0015
54 GRANULOMATOUS LIVER DISEASE 1 0.0014
55 DERMATITIS DIAPER 1 0.0014
56 EYE ROLLING 1 0.0014
57 ORTHOSTATIC INTOLERANCE 1 0.0014
58 GASTROINTESTINAL SURGERY 1 0.0013
59 GRIMACING 1 0.0013
60 VITAMIN B12 INCREASED 1 0.0013
61 MEAN PLATELET VOLUME DECREASED 1 0.0012
62 VITAL FUNCTIONS ABNORMAL 1 0.0012
63 BLOOD CHLORIDE INCREASED 2 0.0012
64 ENDOCRINE OPHTHALMOPATHY 1 0.0012
65 NUCHAL RIGIDITY 1 0.0011
66 INJECTION SITE DRYNESS 1 0.0011
67 THERAPEUTIC RESPONSE INCREASED 1 0.0011
68 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
69 SOMATIC SYMPTOM DISORDER 1 0.0009
70 PNEUMONIA STREPTOCOCCAL 1 0.0009
71 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
72 CARBON DIOXIDE DECREASED 1 0.0009
73 LIP ULCERATION 1 0.0009
74 FEBRILE INFECTION 1 0.0008
75 STERNAL FRACTURE 1 0.0008
76 STEM CELL TRANSPLANT 2 0.0008
77 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
78 AREFLEXIA 2 0.0007
79 VULVOVAGINAL CANDIDIASIS 1 0.0007
80 PRODUCT MONITORING ERROR 1 0.0007
81 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
82 AXILLARY PAIN 1 0.0007
83 APNOEA 5 0.0006
84 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
85 FUNGAEMIA 1 0.0006
86 HEPATITIS E 1 0.0006
87 LYMPHOCYTE COUNT INCREASED 2 0.0006
88 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
89 LACK OF INJECTION SITE ROTATION 1 0.0006
90 VERTIGO POSITIONAL 1 0.0006
91 BURNS SECOND DEGREE 1 0.0006
92 HISTOPLASMOSIS 1 0.0006
93 SOFT TISSUE INFECTION 1 0.0005
94 HAEMATOMA 14 0.0005
95 MECHANICAL VENTILATION 1 0.0005
96 HEPATIC MASS 1 0.0005
97 EARLY SATIETY 1 0.0005
98 MIOSIS 4 0.0005
99 HYPOPHYSITIS 1 0.0005
100 DEVICE RELATED SEPSIS 1 0.0005
101 HYPOTHERMIA 5 0.0005
102 CHANGE OF BOWEL HABIT 1 0.0005
103 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
104 REACTION TO DRUG EXCIPIENTS 1 0.0005
105 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
106 RETROPERITONEAL HAEMATOMA 1 0.0005
107 FAECES PALE 1 0.0004
108 HEPATOCELLULAR DAMAGE 1 0.0004
109 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
110 NEUROLOGICAL DECOMPENSATION 1 0.0004
111 INGROWING NAIL 1 0.0004
112 LACUNAR INFARCTION 1 0.0004
113 SUBCUTANEOUS ABSCESS 2 0.0004
114 NERVOUSNESS 20 0.0004
115 HYDROCEPHALUS 2 0.0004
116 NASAL CONGESTION 21 0.0004
117 OXYGEN SATURATION ABNORMAL 1 0.0004
118 HYPERTONIC BLADDER 1 0.0003
119 INFUSION SITE REACTION 1 0.0003
120 ATYPICAL PNEUMONIA 1 0.0003
121 THYROIDITIS 1 0.0003
122 REBOUND ACID HYPERSECRETION 1 0.0003
123 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
124 SINUS BRADYCARDIA 3 0.0003
125 RHINORRHOEA 20 0.0003
126 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
127 SEDATION 8 0.0003
128 PEPTIC ULCER 1 0.0003
129 WOUND DEHISCENCE 1 0.0003
130 ECCHYMOSIS 2 0.0003
131 APLASIA PURE RED CELL 1 0.0003
132 GRANULOMA 1 0.0003
133 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
134 HALLUCINATION, VISUAL 6 0.0003
135 LOGORRHOEA 1 0.0003
136 MONOCYTE COUNT INCREASED 1 0.0003
137 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
138 AUTOIMMUNE THYROIDITIS 1 0.0003
139 PNEUMONIA FUNGAL 1 0.0003
140 FURUNCLE 2 0.0003
141 MUSCLE HAEMORRHAGE 1 0.0002
142 HYPERURICAEMIA 1 0.0002
143 CONGESTIVE CARDIOMYOPATHY 1 0.0002
144 OROPHARYNGEAL PAIN 22 0.0002
145 MIGRAINE 22 0.0002
146 CHAPPED LIPS 1 0.0002
147 SINUSITIS 23 0.0002
148 PAPILLOEDEMA 1 0.0002
149 VASCULAR DEVICE INFECTION 1 0.0002
150 COLITIS MICROSCOPIC 1 0.0002
151 AUTOIMMUNE DISORDER 2 0.0002
152 INJECTION SITE REACTION 14 0.0002
153 BODY TEMPERATURE DECREASED 2 0.0002
154 APPLICATION SITE BURN 1 0.0002
155 HYPERNATRAEMIA 1 0.0002
156 PROTEIN URINE PRESENT 1 0.0002
157 KLEBSIELLA INFECTION 1 0.0002
158 INFLUENZA 22 0.0002
159 ILLNESS 20 0.0002
160 PARTIAL SEIZURES 1 0.0002
161 POLYARTHRITIS 1 0.0002
162 PHARYNGOLARYNGEAL PAIN 1 0.0002
163 ANAL ABSCESS 1 0.0002
164 CHEILITIS 1 0.0002
165 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
166 MENTAL STATUS CHANGES 5 0.0002
167 CHILLS 21 0.0002
168 BLOOD CALCIUM DECREASED 2 0.0002
169 ASTHMA 20 0.0002
170 INJECTION SITE BRUISING 14 0.0002
171 BACTERAEMIA 2 0.0002
172 SCHIZOPHRENIA 2 0.0002
173 LARYNGEAL OEDEMA 1 0.0002
174 ILEUS 2 0.0002
175 PRE-EXISTING CONDITION IMPROVED 1 0.0002
176 ASPERGILLUS INFECTION 1 0.0002
177 INFECTION 22 0.0002
178 CARDIAC FAILURE ACUTE 1 0.0001
179 POST-TRAUMATIC STRESS DISORDER 1 0.0001
180 BRONCHIECTASIS 1 0.0001
181 GINGIVAL BLEEDING 2 0.0001
182 ONYCHOCLASIS 1 0.0001
183 AUTOIMMUNE HEPATITIS 1 0.0001
184 URTICARIA 24 0.0001
185 BLOOD TEST ABNORMAL 2 0.0001
186 LYMPHADENOPATHY 5 0.0001
187 GRAFT VERSUS HOST DISEASE 1 0.0001
188 ORAL DISORDER 1 0.0001
189 PSYCHIATRIC SYMPTOM 1 0.0001
190 ECONOMIC PROBLEM 2 0.0001
191 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
192 FOOD ALLERGY 1 0.0001
193 MYALGIA 22 0.0001
194 BLOOD ALBUMIN DECREASED 1 0.0001
195 SENSORY LOSS 1 0.0001
196 POLYURIA 1 0.0001
197 ERYTHEMA 25 0.0001
198 NASOPHARYNGITIS 22 0.0001
199 RASH GENERALISED 3 0.0001
200 MUSCLE STRAIN 1 0.0001
201 SPINAL OSTEOARTHRITIS 1 0.0001
202 TUMOUR LYSIS SYNDROME 1 0.0001
203 JAUNDICE 3 0.0001
204 ACCIDENTAL OVERDOSE 4 0.0001
205 INCREASED TENDENCY TO BRUISE 1 0.0001
206 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
207 NEPHROPATHY 1 0.0001
208 FLANK PAIN 1 0.0001
209 LACERATION 1 0.0001
210 DYSPNOEA EXERTIONAL 4 0.0001
211 BLOOD URINE PRESENT 2 0.0001
212 HAEMORRHOIDS 2 0.0001
213 SKIN FISSURES 2 0.0001
214 INFLAMMATORY BOWEL DISEASE 1 0.0001
215 RENAL TUBULAR NECROSIS 1 0.0001
216 SALIVARY HYPERSECRETION 1 0.0001
217 NEUTROPHIL COUNT INCREASED 1 0.0001
218 HYPERBILIRUBINAEMIA 1 0.0001
219 RENAL PAIN 1 0.0001
220 BRADYCARDIA 5 0.0001
221 SKIN LACERATION 1 0.0001
222 OESOPHAGITIS 1 0.0001
223 BACK PAIN 21 0.0001
224 INSOMNIA 24 0.0001
225 MALNUTRITION 1 0.0001
226 INTESTINAL PERFORATION 1 0.0001
227 FISTULA 1 0.0001
228 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
229 ELECTROLYTE IMBALANCE 1 0.0001
230 SPLENOMEGALY 1 0.0001
231 SPINAL PAIN 1 0.0001
232 COVID-19 PNEUMONIA 1 0.0001
233 COMA 4 0.0001
234 ADRENAL INSUFFICIENCY 1 0.0001
235 COUGH 23 0.0001
236 RESPIRATORY DEPRESSION 1 0.0001
237 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
238 SPINAL OPERATION 1 0.0001
239 EYE SWELLING 3 0.0001
240 PHARYNGITIS 1 0.0001
241 DERMATITIS ALLERGIC 1 0.0001
242 BRAIN OEDEMA 1 0.0001
243 COLITIS 3 0.0001
244 CHRONIC KIDNEY DISEASE 6 0.0001
245 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
246 ANOREXIA 1 0.0001
247 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
248 PNEUMONIA 25 0.0001
249 PLATELET COUNT INCREASED 1 0.0001
250 IMMUNE SYSTEM DISORDER 1 0.0001
251 PULMONARY CONGESTION 1 0.0001
252 EYE HAEMORRHAGE 1 0.0001
253 MENSTRUATION IRREGULAR 2 0.0001
254 IMPAIRED GASTRIC EMPTYING 1 0.0001
255 ACUTE HEPATIC FAILURE 1 0.0001
256 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
257 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
258 FLATULENCE 4 0.0001
259 PRURITUS 27 0.0001
260 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
261 IMPAIRED QUALITY OF LIFE 1 0.0001
262 HYPERTHYROIDISM 1 0.0001
263 SEPTIC SHOCK 3 0.0001
264 APATHY 1 0.0001
265 GASTROENTERITIS 1 0.0001
266 AGITATION 5 0.0001
267 HALLUCINATION 5 0.0001
268 HEPATIC FAILURE 2 0.0001
269 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
270 SKIN DISCOLOURATION 3 0.0001
271 PHARYNGEAL OEDEMA 1 0.0001
272 DEVICE RELATED INFECTION 1 0.0001
273 DELUSION 1 0.0001
274 THERAPY PARTIAL RESPONDER 1 0.0001
275 PRODUCT USE COMPLAINT 1 0.0001
276 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
277 ABSCESS 1 0.0001
278 METABOLIC ACIDOSIS 2 0.0001
279 MOVEMENT DISORDER 2 0.0001
280 NIGHT SWEATS 2 0.0001
281 MUSCLE TIGHTNESS 1 0.0001
282 BLOOD POTASSIUM INCREASED 1 0.0001
283 VENTRICULAR TACHYCARDIA 1 0.0001
284 DRUG LEVEL INCREASED 1 0.0001
285 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
286 RENAL FAILURE 8 0.0001
287 LIP SWELLING 2 0.0001
288 BLOOD UREA INCREASED 1 0.0001
289 CELLULITIS 3 0.0001
290 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
291 INFLAMMATION 3 0.0001
292 MUSCULOSKELETAL DISCOMFORT 1 0.0001
293 EOSINOPHILIA 1 0.0001
294 AMENORRHOEA 1 0.0001
295 METASTASES TO LIVER 1 0.0001
296 LYMPHOCYTE COUNT DECREASED 1 0.0001
297 THIRST 1 0.0001
298 OSTEOMYELITIS 1 0.0001
299 RESTLESS LEGS SYNDROME 1 0.0001
300 END STAGE RENAL DISEASE 1 0.0001
301 RESTLESSNESS 2 0.0001
302 INJECTION SITE MASS 2 0.0001
303 CONJUNCTIVITIS 1 0.0001
304 DYSGEUSIA 4 0.0001
305 AGRANULOCYTOSIS 1 0.0001
306 NECK PAIN 3 0.0001
307 MIDDLE INSOMNIA 1 0.0001
308 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
309 BLOOD SODIUM DECREASED 1 0.0001
310 PROTEINURIA 1 0.0001
311 SLEEP APNOEA SYNDROME 1 0.0001
312 INCREASED APPETITE 1 0.0001
313 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
314 ERUCTATION 1 0.0001
315 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
316 HAEMATOCRIT DECREASED 1 0.0001
317 CYTOKINE RELEASE SYNDROME 1 0.0000
318 HYPOTENSION 10 0.0000
319 STOMATITIS 3 0.0000
320 OEDEMA PERIPHERAL 6 0.0000
321 DYSKINESIA 2 0.0000
322 DISCOMFORT 3 0.0000
323 PAIN 30 0.0000
324 PERITONITIS 1 0.0000
325 TOOTH LOSS 1 0.0000
326 INTENTIONAL DRUG MISUSE 1 0.0000
327 RETCHING 1 0.0000
328 IMPAIRED WORK ABILITY 1 0.0000
329 IRRITABLE BOWEL SYNDROME 1 0.0000
330 MENTAL DISORDER 2 0.0000
331 APPLICATION SITE PAIN 1 0.0000
332 STEVENS-JOHNSON SYNDROME 1 0.0000
333 TRANSAMINASES INCREASED 1 0.0000
334 HEPATOTOXICITY 1 0.0000
335 ORAL PAIN 1 0.0000
336 CHROMATURIA 1 0.0000
337 HEART RATE IRREGULAR 1 0.0000
338 DYSPNOEA 25 0.0000
339 TINNITUS 2 0.0000
340 SHOCK 1 0.0000
341 FALL 14 0.0000
342 SKIN BURNING SENSATION 3 0.0000
343 MENTAL IMPAIRMENT 1 0.0000
344 HYPOGLYCAEMIA 2 0.0000
345 RESPIRATORY FAILURE 3 0.0000
346 FIBROMYALGIA 1 0.0000
347 PRESYNCOPE 1 0.0000
348 NEURALGIA 1 0.0000
349 FATIGUE 32 0.0000
350 LIVER INJURY 1 0.0000
351 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
352 PNEUMONIA ASPIRATION 1 0.0000
353 ABDOMINAL PAIN LOWER 1 0.0000
354 GASTRIC CANCER 1 0.0000
355 CARDIOVASCULAR DISORDER 1 0.0000
356 HYPOPHAGIA 1 0.0000
357 HEPATITIS 1 0.0000
358 ERECTILE DYSFUNCTION 1 0.0000
359 DIPLOPIA 1 0.0000
360 HEADACHE 24 0.0000
361 DEAFNESS 1 0.0000
362 MUSCULOSKELETAL PAIN 2 0.0000
363 JOINT STIFFNESS 1 0.0000
364 ANHEDONIA 1 0.0000
365 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
366 CARDIAC FAILURE 3 0.0000
367 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
368 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
369 OEDEMA 2 0.0000
370 PALLOR 1 0.0000
371 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
372 HAEMATOCHEZIA 2 0.0000
373 COMPLETED SUICIDE 3 0.0000
374 FEELING COLD 1 0.0000
375 OXYGEN SATURATION DECREASED 2 0.0000
376 HYPONATRAEMIA 2 0.0000
377 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
378 RED BLOOD CELL COUNT DECREASED 1 0.0000
379 CONVULSION 2 0.0000
380 HYPERSOMNIA 1 0.0000
381 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
382 DYSSTASIA 1 0.0000
383 PALPITATIONS 4 0.0000
384 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
385 ASCITES 1 0.0000
386 ACUTE MYOCARDIAL INFARCTION 1 0.0000
387 PSYCHOTIC DISORDER 1 0.0000
388 TACHYCARDIA 3 0.0000
389 RENAL INJURY 1 0.0000
390 APHASIA 1 0.0000
391 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
392 PLEURAL EFFUSION 2 0.0000
393 ACUTE KIDNEY INJURY 5 0.0000
394 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
395 EMOTIONAL DISORDER 1 0.0000
396 VISUAL IMPAIRMENT 4 0.0000
397 BONE DENSITY DECREASED 1 0.0000
398 MOOD SWINGS 1 0.0000
399 SWELLING FACE 2 0.0000
400 DYSPEPSIA 3 0.0000
401 IMPAIRED HEALING 1 0.0000
402 OSTEONECROSIS 1 0.0000
403 STAPHYLOCOCCAL INFECTION 1 0.0000
404 HEART RATE INCREASED 3 0.0000
405 FEBRILE NEUTROPENIA 2 0.0000
406 VISUAL ACUITY REDUCED 1 0.0000
407 FUNGAL INFECTION 1 0.0000
408 SYNCOPE 3 0.0000
409 URINARY RETENTION 1 0.0000
410 DRY SKIN 4 0.0000
411 TOXICITY TO VARIOUS AGENTS 5 0.0000
412 HAEMATURIA 1 0.0000
413 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
414 BURNING SENSATION 2 0.0000
415 HYPOXIA 1 0.0000
416 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
417 ANXIETY 8 0.0000
418 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
419 DYSURIA 1 0.0000
420 BRONCHITIS 2 0.0000
421 HEPATIC FUNCTION ABNORMAL 1 0.0000
422 EPISTAXIS 2 0.0000
423 HOT FLUSH 2 0.0000
424 HOSPITALISATION 4 0.0000
425 PYREXIA 9 0.0000
426 VOMITING 12 0.0000
427 ALOPECIA 5 0.0000
428 NAUSEA 20 0.0000
429 ABNORMAL BEHAVIOUR 1 0.0000
430 SOMNOLENCE 5 0.0000
431 INFLUENZA LIKE ILLNESS 2 0.0000
432 POLLAKIURIA 1 0.0000
433 CARDIO-RESPIRATORY ARREST 1 0.0000
434 ROAD TRAFFIC ACCIDENT 1 0.0000
435 OSTEOARTHRITIS 1 0.0000
436 HYPERHIDROSIS 3 0.0000
437 RECTAL HAEMORRHAGE 1 0.0000
438 HYPOACUSIS 1 0.0000
439 CONSTIPATION 5 0.0000
440 MUSCULOSKELETAL STIFFNESS 2 0.0000
441 ANGIOEDEMA 1 0.0000
442 DEHYDRATION 3 0.0000
443 NEUTROPENIA 3 0.0000
444 SKIN IRRITATION 1 0.0000
445 MUSCLE SPASMS 4 0.0000
446 HYPOKALAEMIA 1 0.0000
447 HYPERSENSITIVITY 4 0.0000
448 ABDOMINAL PAIN 5 0.0000
449 COGNITIVE DISORDER 1 0.0000
450 ARRHYTHMIA 1 0.0000
451 DYSPHAGIA 2 0.0000
452 DISEASE RECURRENCE 1 0.0000
453 ANAEMIA 4 0.0000
454 PRODUCTIVE COUGH 1 0.0000
455 BLOOD GLUCOSE DECREASED 1 0.0000
456 PAIN IN EXTREMITY 6 0.0000
457 DRY EYE 1 0.0000
458 FLUID RETENTION 1 0.0000
459 CHEST DISCOMFORT 2 0.0000
460 THERAPY CESSATION 1 0.0000
461 ABDOMINAL DISTENSION 2 0.0000
462 ECZEMA 1 0.0000
463 DERMATITIS ATOPIC 1 0.0000
464 PLATELET COUNT DECREASED 2 0.0000
465 DISTURBANCE IN ATTENTION 1 0.0000
466 RASH PRURITIC 1 0.0000
467 TREMOR 3 0.0000
468 THROMBOCYTOPENIA 2 0.0000
469 CEREBROVASCULAR ACCIDENT 3 0.0000
470 RHEUMATOID ARTHRITIS 2 0.0000
471 DEPRESSION 4 0.0000
472 LETHARGY 1 0.0000
473 EYE IRRITATION 1 0.0000
474 PRODUCT SUBSTITUTION ISSUE 1 0.0000
475 DYSPHONIA 1 0.0000
476 DISEASE PROGRESSION 2 0.0000
477 CATARACT 1 0.0000
478 IRRITABILITY 1 0.0000
479 JOINT SWELLING 2 0.0000
480 EMOTIONAL DISTRESS 2 0.0000
481 SUICIDE ATTEMPT 1 0.0000
482 DIZZINESS 8 0.0000
483 BLOOD GLUCOSE INCREASED 3 0.0000
484 GAIT DISTURBANCE 3 0.0000
485 LOSS OF CONSCIOUSNESS 2 0.0000
486 DEEP VEIN THROMBOSIS 1 0.0000
487 AMNESIA 1 0.0000
488 BLOOD CREATININE INCREASED 1 0.0000
489 INJECTION SITE PRURITUS 1 0.0000
490 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
491 MEMORY IMPAIRMENT 2 0.0000
492 INJURY 1 0.0000
493 SLEEP DISORDER 1 0.0000
494 THERAPY INTERRUPTED 1 0.0000
495 OFF LABEL USE 12 0.0000
496 ASTHENIA 5 0.0000
497 ACNE 1 0.0000
498 INCORRECT DOSE ADMINISTERED 3 0.0000
499 INJECTION SITE SWELLING 1 0.0000
500 DECREASED APPETITE 3 0.0000
501 ARTHRITIS 1 0.0000
502 DRUG INTERACTION 2 0.0000
503 FEELING ABNORMAL 3 0.0000
504 THROMBOSIS 1 0.0000
505 CONFUSIONAL STATE 2 0.0000
506 TREATMENT FAILURE 1 0.0000
507 ARTHRALGIA 5 0.0000
508 DRUG ABUSE 1 0.0000
509 ABDOMINAL DISCOMFORT 2 0.0000
510 SKIN EXFOLIATION 1 0.0000
511 URINARY TRACT INFECTION 2 0.0000
512 RASH 5 0.0000
513 COVID-19 2 0.0000
514 DRUG INEFFECTIVE 15 0.0000
515 GASTROINTESTINAL DISORDER 1 0.0000
516 DEVICE ISSUE 1 0.0000
517 SUICIDAL IDEATION 1 0.0000
518 WEIGHT DECREASED 3 0.0000
519 BREAST CANCER 1 0.0000
520 NEUROPATHY PERIPHERAL 1 0.0000
521 CONTUSION 1 0.0000
522 FLUSHING 1 0.0000
523 INJECTION SITE PAIN 3 0.0000
524 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
525 HAEMOGLOBIN DECREASED 1 0.0000
526 HAEMORRHAGE 1 0.0000
527 MALAISE 4 0.0000
528 SEIZURE 1 0.0000
529 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
530 INJECTION SITE ERYTHEMA 1 0.0000
531 PRODUCT QUALITY ISSUE 1 0.0000
532 VISION BLURRED 1 0.0000
533 CONDITION AGGRAVATED 2 0.0000
534 BLOOD PRESSURE INCREASED 1 0.0000
535 PARAESTHESIA 1 0.0000
536 DIARRHOEA 4 0.0000
537 DEATH 5 0.0000
538 CHEST PAIN 1 0.0000
539 PRODUCT USE ISSUE 1 0.0000
540 ABDOMINAL PAIN UPPER 1 0.0000
541 OVERDOSE 1 0.0000
542 WEIGHT INCREASED 1 0.0000